Oppenheimer Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Oppenheimer Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-674	Closed	-$59K	–	1512
2020 Q1	$59K	Sell	674 -62	-8%	-$6.57K	﹤0.01%	1228
2019 Q4	$76K	Buy	736 +84	+13%	+$9.42K	﹤0.01%	1261
2019 Q3	$75K	Buy	652 +66	+11%	+$10K	﹤0.01%	1261
2019 Q2	$101K	Sell	586 -15	-2%	-$2.59K	﹤0.01%	1224
2019 Q1	$101K	Buy	601 +78	+15%	+$11.6K	﹤0.01%	1206
2018 Q4	$51K	Buy	+523	New	+$68.6K	﹤0.01%	1345
2017 Q4	–	Sell	-2	Closed	–	–	1576
2017 Q3	$0	Buy	+2	New	+$214	﹤0.01%	1726

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Oppenheimer Asset Management's GWPH Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 674 shares — an estimated $59K sold.

Oppenheimer Asset Management first reported a position in GWPH in Q3 2017 and held it in 7 quarters. The position peaked at $101K in Q2 2019. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

Oppenheimer Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Oppenheimer Asset Management sold 674 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $59K.
Oppenheimer Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 7 quarters.
Oppenheimer Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $101K in Q2 2019.
299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.